Floatz logo

Irradiated Allogeneic Cells

RAS Family Gene Mutation

Rutgers, The State University of New JerseyCell therapyEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the RAS Family Gene Mutation cohort.

Asset / SponsorPhaseRating
Trifluridine
City of Hope Medical Center
Phase 1CC
gsk1120212
City of Hope Medical Center
Phase 1CC
TIPIRACIL
City of Hope Medical Center
Phase 1CC

Same molecule, other indications

Irradiated Allogeneic Cells is also rated in:

acute myeloid leukemiaDormant
C
Indicative ·
39 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
C
Indicative ·
39 / 100
View asset →
myeloid/lymphoid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB, FGFR1 or JAK2Dormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →